Science and innovation: the US pharmaceutical industry during the 1980s
This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are b...
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge
Cambridge University Press
1995
|
| Schlagwörter: | |
| Links: | https://doi.org/10.1017/CBO9780511522031 https://doi.org/10.1017/CBO9780511522031 https://doi.org/10.1017/CBO9780511522031 |
| Zusammenfassung: | This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D. |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Umfang: | 1 online resource (xvi, 199 pages) |
| ISBN: | 9780511522031 |
| DOI: | 10.1017/CBO9780511522031 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043928666 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161202s1995 xx o|||| 00||| eng d | ||
| 020 | |a 9780511522031 |c Online |9 978-0-511-52203-1 | ||
| 024 | 7 | |a 10.1017/CBO9780511522031 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511522031 | ||
| 035 | |a (OCoLC)967422254 | ||
| 035 | |a (DE-599)BVBBV043928666 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-473 | ||
| 082 | 0 | |a 338.4/76151/097309048 |2 20 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Gambardella, Alfonso |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Science and innovation |b the US pharmaceutical industry during the 1980s |c Alfonso Gambardella |
| 246 | 1 | 3 | |a Science & Innovation |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 1995 | |
| 300 | |a 1 online resource (xvi, 199 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | |a 1. Introduction -- 2. Science and innovation in pharmaceutical research -- 3. Economic implications of greater scientific intensity in drug research -- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies -- 5. Scientific research and drug discovery: an econometric investigation -- 6. A model of the innovation cycle in the pharmaceutical industry -- 7. Complementarity and external linkages: the strategies of large firms in biotechnology -- 8. Conclusions | |
| 520 | |a This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D. | ||
| 648 | 4 | |a Geschichte 1900-2000 | |
| 648 | 7 | |a Geschichte 1980-1989 |2 gnd |9 rswk-swf | |
| 650 | 4 | |a Geschichte | |
| 650 | 4 | |a Pharmaceutical industry / United States | |
| 650 | 4 | |a Pharmaceutical industry / Technological innovations / United States / History / 20th century | |
| 650 | 4 | |a Drugs / Research / United States / Costs | |
| 650 | 4 | |a Pharmacy / Research / United States / Costs | |
| 650 | 0 | 7 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |D s |
| 689 | 0 | 3 | |a Geschichte 1980-1989 |A z |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-06206-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-45118-5 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511522031 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-029337745 | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511522031 |l DE-12 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511522031 |l DE-473 |p ZDB-20-CBO |q UBG_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818982543756623872 |
|---|---|
| any_adam_object | |
| author | Gambardella, Alfonso |
| author_facet | Gambardella, Alfonso |
| author_role | aut |
| author_sort | Gambardella, Alfonso |
| author_variant | a g ag |
| building | Verbundindex |
| bvnumber | BV043928666 |
| classification_rvk | QR 525 |
| collection | ZDB-20-CBO |
| contents | 1. Introduction -- 2. Science and innovation in pharmaceutical research -- 3. Economic implications of greater scientific intensity in drug research -- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies -- 5. Scientific research and drug discovery: an econometric investigation -- 6. A model of the innovation cycle in the pharmaceutical industry -- 7. Complementarity and external linkages: the strategies of large firms in biotechnology -- 8. Conclusions |
| ctrlnum | (ZDB-20-CBO)CR9780511522031 (OCoLC)967422254 (DE-599)BVBBV043928666 |
| dewey-full | 338.4/76151/097309048 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151/097309048 |
| dewey-search | 338.4/76151/097309048 |
| dewey-sort | 3338.4 576151 897309048 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1017/CBO9780511522031 |
| era | Geschichte 1900-2000 Geschichte 1980-1989 gnd |
| era_facet | Geschichte 1900-2000 Geschichte 1980-1989 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03979nam a2200625zc 4500</leader><controlfield tag="001">BV043928666</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161202s1995 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511522031</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-52203-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511522031</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511522031</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)967422254</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043928666</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151/097309048</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gambardella, Alfonso</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Science and innovation</subfield><subfield code="b">the US pharmaceutical industry during the 1980s</subfield><subfield code="c">Alfonso Gambardella</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Science & Innovation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvi, 199 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">1. Introduction -- 2. Science and innovation in pharmaceutical research -- 3. Economic implications of greater scientific intensity in drug research -- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies -- 5. Scientific research and drug discovery: an econometric investigation -- 6. A model of the innovation cycle in the pharmaceutical industry -- 7. Complementarity and external linkages: the strategies of large firms in biotechnology -- 8. Conclusions</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D.</subfield></datafield><datafield tag="648" ind1=" " ind2="4"><subfield code="a">Geschichte 1900-2000</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte 1980-1989</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Geschichte</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Technological innovations / United States / History / 20th century</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Research / United States / Costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy / Research / United States / Costs</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Geschichte 1980-1989</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-06206-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-45118-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511522031</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029337745</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511522031</subfield><subfield code="l">DE-12</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511522031</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">UBG_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV043928666 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T17:48:53Z |
| institution | BVB |
| isbn | 9780511522031 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029337745 |
| oclc_num | 967422254 |
| open_access_boolean | |
| owner | DE-12 DE-473 DE-BY-UBG |
| owner_facet | DE-12 DE-473 DE-BY-UBG |
| physical | 1 online resource (xvi, 199 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO UBG_PDA_CBO |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Gambardella, Alfonso Verfasser aut Science and innovation the US pharmaceutical industry during the 1980s Alfonso Gambardella Science & Innovation Cambridge Cambridge University Press 1995 1 online resource (xvi, 199 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) 1. Introduction -- 2. Science and innovation in pharmaceutical research -- 3. Economic implications of greater scientific intensity in drug research -- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies -- 5. Scientific research and drug discovery: an econometric investigation -- 6. A model of the innovation cycle in the pharmaceutical industry -- 7. Complementarity and external linkages: the strategies of large firms in biotechnology -- 8. Conclusions This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D. Geschichte 1900-2000 Geschichte 1980-1989 gnd rswk-swf Geschichte Pharmaceutical industry / United States Pharmaceutical industry / Technological innovations / United States / History / 20th century Drugs / Research / United States / Costs Pharmacy / Research / United States / Costs Forschung und Entwicklung (DE-588)4017897-3 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Pharmazeutische Industrie (DE-588)4045696-1 s Forschung und Entwicklung (DE-588)4017897-3 s Geschichte 1980-1989 z 1\p DE-604 Erscheint auch als Druckausgabe 978-0-521-06206-0 Erscheint auch als Druckausgabe 978-0-521-45118-5 https://doi.org/10.1017/CBO9780511522031 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Gambardella, Alfonso Science and innovation the US pharmaceutical industry during the 1980s 1. Introduction -- 2. Science and innovation in pharmaceutical research -- 3. Economic implications of greater scientific intensity in drug research -- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies -- 5. Scientific research and drug discovery: an econometric investigation -- 6. A model of the innovation cycle in the pharmaceutical industry -- 7. Complementarity and external linkages: the strategies of large firms in biotechnology -- 8. Conclusions Geschichte Pharmaceutical industry / United States Pharmaceutical industry / Technological innovations / United States / History / 20th century Drugs / Research / United States / Costs Pharmacy / Research / United States / Costs Forschung und Entwicklung (DE-588)4017897-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4017897-3 (DE-588)4045696-1 (DE-588)4078704-7 |
| title | Science and innovation the US pharmaceutical industry during the 1980s |
| title_alt | Science & Innovation |
| title_auth | Science and innovation the US pharmaceutical industry during the 1980s |
| title_exact_search | Science and innovation the US pharmaceutical industry during the 1980s |
| title_full | Science and innovation the US pharmaceutical industry during the 1980s Alfonso Gambardella |
| title_fullStr | Science and innovation the US pharmaceutical industry during the 1980s Alfonso Gambardella |
| title_full_unstemmed | Science and innovation the US pharmaceutical industry during the 1980s Alfonso Gambardella |
| title_short | Science and innovation |
| title_sort | science and innovation the us pharmaceutical industry during the 1980s |
| title_sub | the US pharmaceutical industry during the 1980s |
| topic | Geschichte Pharmaceutical industry / United States Pharmaceutical industry / Technological innovations / United States / History / 20th century Drugs / Research / United States / Costs Pharmacy / Research / United States / Costs Forschung und Entwicklung (DE-588)4017897-3 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | Geschichte Pharmaceutical industry / United States Pharmaceutical industry / Technological innovations / United States / History / 20th century Drugs / Research / United States / Costs Pharmacy / Research / United States / Costs Forschung und Entwicklung Pharmazeutische Industrie USA |
| url | https://doi.org/10.1017/CBO9780511522031 |
| work_keys_str_mv | AT gambardellaalfonso scienceandinnovationtheuspharmaceuticalindustryduringthe1980s AT gambardellaalfonso scienceinnovation |